M&A analysts remain bullish
The end of 2008 was a rollercoaster ride, with the HME industry preparing to absorb not one but two reimbursement cuts on Jan. 1. Still, analysts expect a strong showing by the mergers-and-acquisitions market for HME in 2009.
“People are cautiously optimistic,” said Bob Leonard, an analyst with The Braff Group, an M&A firm in Pittsburgh.
On Jan. 1, providers will absorb a 9.5% nationwide reimbursement cut for all product categories included in the first round of national competitive bidding. Additionally, they must stop billing Medicare for equipment for patients who have been on oxygen for 36 months.
Although reimbursement cuts have affected valuations for HME companies, they haven’t affected the appetite of buyers looking to capitalize on the growing healthcare industry, analysts say.
“I think things are going to improve, especially for larger companies,” said Jonathan Sadock, a managing partner with Paragon Ventures, a Philadelphia-based M&A firm.
Prices may be off, but there haven’t been any fire sales, a sign that providers, knowing the HME industry has long-term value, are willing to weather the storm, analysts say.
“I can’t see prices going lower, because there’s a point where buyers don’t have to sell,” said Gina Bienkowski, vice president of Ultimate Resource, an M&A firm in Newtown, Pa. “They can just ride it out.”
Thankfully, the slumping economy and the credit crisis haven’t really had a trickle-down effect on M&A for HME, analysts say.
“I don’t know of anyone having a problem (getting credit),” said Rick Glass, president of Steven Richards & Associates, an M&A firm in Tarpon Springs, Fla.